Author Correction: Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Author Correction: Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers ; volume:14 ; number:1 ; day:3 ; month:7 ; year:2024 ; pages:1 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.7.2024), 1, 12.2024
- Urheber
-
Rykkelid, Anne Marit
Sinha, Priyanshu Manojkumar
Folefac, Charlemagne Asonganyi
Horsman, Michael R.
Sørensen, Brita Singers
Søland, Tine Merete
Schreurs, Olaf Joseph Franciscus
Malinen, Eirik
Edin, Nina Frederike J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-66148-0
- URN
-
urn:nbn:de:101:1-2409231221209.958871018728
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rykkelid, Anne Marit
- Sinha, Priyanshu Manojkumar
- Folefac, Charlemagne Asonganyi
- Horsman, Michael R.
- Sørensen, Brita Singers
- Søland, Tine Merete
- Schreurs, Olaf Joseph Franciscus
- Malinen, Eirik
- Edin, Nina Frederike J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers
Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers
Immunotherapy in Rare Cancers
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1
Immunotherapy : new options in gastrointestinal cancers?
PD-L1 degradation pathway and immunotherapy for cancer
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regulatory mechanisms of PD-1/PD-L1 in cancers
Clinical applications of PD-L1 bioassays for cancer immunotherapy
Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers
Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers
Immunotherapy in Rare Cancers
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1
Immunotherapy : new options in gastrointestinal cancers?
PD-L1 degradation pathway and immunotherapy for cancer
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regulatory mechanisms of PD-1/PD-L1 in cancers
Clinical applications of PD-L1 bioassays for cancer immunotherapy
Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers
Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers
Immunotherapy in Rare Cancers
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1
Immunotherapy : new options in gastrointestinal cancers?
PD-L1 degradation pathway and immunotherapy for cancer
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Regulatory mechanisms of PD-1/PD-L1 in cancers